KRYS logo

KRYS

Krystal Biotech Inc.

$165.42
+$1.85(+1.13%)
73
Overall
65
Value
81
Tech
--
Quality
Market Cap
$4.47B
Volume
461.90K
52W Range
$122.80 - $207.84
Target Price
$207.30
Order:

Income Statement

MetricTrendChart
2017
Dec
2019
Dec
2020
Dec
2021
Dec
2022
Dec
2023
Dec
2024
Dec
REVENUE
Total Revenue
----------$50.7M$290.5M
Total Revenue
----------$50.7M$290.5M
COST OF GOODS SOLD
Cost of Revenue
----------$3.1M--
GROSS PROFIT
Gross Profit
----------$50.7M$290.5M
OPERATING EXPENSES
Operating Expenses
$-4.8M$-22.1M$33.0M$68.3M$120.2M$160.4M$224.8M
Research & Development
$3.2M$15.6M$17.9M$27.9M$42.5M$46.4M$53.6M
Research Expense
$3.2M$15.6M$17.9M$27.9M$42.5M$46.4M$53.6M
Selling, General & Administrative
$1.6M$6.5M$15.1M$40.4M$77.7M$98.4M$113.7M
General & Administrative Expenses
$1.6M$6.5M$15.1M$40.4M$77.7M$98.4M$113.7M
Salaries & Wages
$-246.0K$-1.2M$34.0K$284.0K$31.4M----
Depreciation & Amortization
$-23.0K$-748.0K$1.5M$1.8M$2.6M$5.0M$6.0M
Depreciation & Amortization
$-23.0K$-748.0K$1.5M$1.8M$2.6M$5.0M$6.0M
Other Operating Expenses
----$767.0K$1.4M$1.8M$1.8M$-4.2M
OPERATING INCOME
Operating income
$-4.8M$-22.1M$-33.0M$-68.3M$-145.2M$-109.7M$65.7M
EBITDA
$-7.9M$-21.0M$-30.3M$-66.2M$-146.4M$18.8M$102.1M
NON-OPERATING ITEMS
Interest Expense (Non-Operating)
------$1.5M------
Intinc
$-3.1M--------$22.6M$29.7M
Net Non-Operating Interest Income/Expense
$-3.1M----$-1.5M$-5.2M$22.6M$29.7M
Other Income/Expense
--------$-25.0M$-100.0M$21.5M
Other Special Charges
----------$100.0M--
SPECIAL ITEMS
Special Income Charges
------$560.0K$-25.0M$-12.5M$-37.5M
PRE-TAX INCOME
EBIT
$-7.9M$-22.1M$-32.2M$-68.1M$-150.4M$12.9M$95.4M
Pre-Tax Income
$-7.9M$-22.1M$-33.0M$-69.8M$-140.0M$12.9M$95.4M
INCOME TAX
Tax Provision
$-1.0M--$-2.6M$-5.4M$-10.4M$2.0M$6.2M
NET INCOME
Net Income
$-7.9M$-19.1M$-32.2M$-69.6M$-140.0M$10.9M$89.2M
Net Income (Continuing Operations)
$-7.9M$-19.1M$-32.2M$-69.6M$-140.0M$10.9M$89.2M
Net Income (Discontinued Operations)
$-7.9M$-19.1M$-32.2M$-69.6M$-140.0M$10.9M$89.2M
Net Income (Common Stockholders)
$-7.9M$-19.1M$-32.2M$-69.6M$-140.0M$10.9M$89.2M
Normalized Income
------------$153.4M
TOTALS
Total Expenses
$-4.8M$-22.1M$33.0M$68.3M$120.2M$160.4M$224.8M
SHARE & EPS DATA
Average Shares Outstanding
$5.4M$15.9M$18.8M$22.2M$25.5M$27.2M$28.6M
Average Shares Outstanding (Diluted)
$5.4M$15.9M--$22.2M$25.5M$27.8M$29.7M
Shares Outstanding
$10.3M$17.4M$22.2M$25.2M$25.8M$28.3M$28.8M
Basic EPS
----$-1.71$-3.13$-5.49$0.40$3.12
Basic EPS (Continuing Operations)
----$-1.71$-3.13$-5.49$0.40$3.12
Diluted EPS
$-1.48$-1.2$-1.71$-3.13$-5.49$0.39$3
Diluted EPS (Continuing Operations)
------$-3.13$-5.49$0.39$3
OTHER METRICS
Net Income From Other Gains Losses
--$3.0M$832.0K$197.0K------
Non Recurring Operation Expense
------$-560.0K$25.0M$12.5M$37.5M
Other Gand A
$1.6M$6.5M$15.1M$40.4M$77.7M$98.4M$113.7M
Other Write Off
----------$363.0K$21.5M
Rent And Landing Fees
$1.6M$6.5M----------

Financial data is updated quarterly and may not reflect the most recent earnings.

ABCD
1SymbolPriceChangeVol
2KRYS$165.42+1.1%461.90K
3
4
5
6

Get Krystal Biotech Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.